Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Marianna Martino, Nairus Aboud, Beatrice Lucchetti, Gianmaria Salvio & Giorgio Arnaldi. (2023) An evaluation of pharmacological options for Cushing’s disease: what are the state-of-the-art options?. Expert Opinion on Pharmacotherapy 24:5, pages 557-576.
Read now
Read now
Edgar G Durán-Pérez, Oscar T Moreno-Loza, German Carrasco-Tobón & Antonio Segovia-Palomo. (2012) Optimal management of Cushing syndrome. Research and Reports in Endocrine Disorders 2, pages 19-30.
Read now
Read now
Georg Feldmann, Savita Bisht, Ute Schütte, Jens Haarmann & Peter Brossart. (2012)
Everolimus for the treatment of pancreatic neuroendocrine tumors. Expert Opinion on Pharmacotherapy 13:14, pages 2073-2084.
Read now
Read now
R Krysiak, A Kędzia & B Okopień. (2012) CYCLIC CUSHING’S SYNDROME. Acta Clinica Belgica 67:1, pages 30-33.
Read now
Read now
Articles from other publishers (11)
Nairui Zhao, Xinxin Yang, Cuiliu Li, Jie Ma & Xiuping Yin. (2020) Efficacy and safety of pasireotide for Cushing's disease. Medicine 99:51, pages e23824.
Crossref
Crossref
Mattia Barbot, Valentina Guarnotta, Marialuisa Zilio, Filippo Ceccato, Alessandro Ciresi, Andrea Daniele, Giuseppe Pizzolanti, Elena Campello, Anna Chiara Frigo, Carla Giordano & Carla Scaroni. (2018) Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease. Endocrine 62:1, pages 207-214.
Crossref
Crossref
Xiaohai Liu, Ming Feng, Ye Zhang, Congxin Dai, Bowen Sun, Xinjie Bao, Kan Deng, Yong Yao & Renzhi Wang. (2018) Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone–Secreting Pituitary Tumors and Their Association with Tumor Recurrence. World Neurosurgery 113, pages e213-e221.
Crossref
Crossref
Barbara Mariniello. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
5070
5077
.
Alejandro Ibáñez-Costa & Márta Korbonits. (2017) AIP and the somatostatin system in pituitary tumours. Journal of Endocrinology 235:3, pages R101-R116.
Crossref
Crossref
Rosario Pivonello, Monica De Leo, Alessia Cozzolino & Annamaria Colao. (2015) The Treatment of Cushing's Disease. Endocrine Reviews 36:4, pages 385-486.
Crossref
Crossref
Laura Trementino, Marina Cardinaletti, Carolina Concettoni, Giorgia Marcelli, Marco Boscaro & Giorgio Arnaldi. (2014) Up-to 5-year efficacy of pasireotide in a patient with Cushing’s disease and pre-existing diabetes: literature review and clinical practice considerations. Pituitary 18:3, pages 359-365.
Crossref
Crossref
Niels Eckstein, Bodo Haas, Moritz David Sebastian Hass & Vladlena Pfeifer. (2014) Systemic therapy of Cushing’s syndrome. Orphanet Journal of Rare Diseases 9:1.
Crossref
Crossref
Joanne Bronson, Amelia Black, T. G. Murali Dhar, Bruce A. Ellsworth & J. Robert Merritt. 2013.
471
546
.
Marina Basina, Hau Liu, Andrew R. Hoffman & David Feldman. (2012) Successful Long-Term Treatment of Cushing Disease with Mifepristone (RU486). Endocrine Practice 18:5, pages e114-e120.
Crossref
Crossref
Brian R. Dempsey, Anne C. Rintala-Dempsey, Gary S. Shaw, Yuan Xiao Zhu, A. Keith Stewart, Jaime O. Claudio, Constance E. Runyan, H. William Schnaper, Philip D. King, Matthew D. Blunt, Stephen G. Ward, Annegret Reinhold, Burkhart L. Schraven, Mitsunori Fukuda, Jong Ran Lee, Julia Strebovsky, Alexander H. Dalpke, Barbara Mariniello, Kaitlyn Ryan, Chin Chiang, Ashok Kumar, Julie D. Saba, David A. Jans, Gurpreet Kaur, Marc J. Tetel, Pui Man Rosalind Lai, Pradeep Kurup, Jian Xu, Susan Goebel-Goody, Surojit Paul, Paul Lombroso, Pia Ragno, Robert R. Bowers, Danyelle M. Townsend, Kenneth D. Tew, Payel Sen, Nilanjana Chatterjee, Blaine Bartholomew & Arie Horowitz. 2012. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1759
1765
.